FMP
Tetra Bio-Pharma Inc.
TBP.TO
TSX
Inactive Equity
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.
0.025 CAD
0 (0%)
About
ceo
Dr. Guy Chamberland M.Sc., Master Herbal
sector
Healthcare
industry
Biotechnology
website
https://www.tetrabiopharma.com
exchange
TSX
Description
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.
CIK
N/A
ISIN
CA88166Y1007
CUSIP
N/A
Address
2316 St. Joseph Boulevard
Phone
343 780 2020
Country
CA
Employee
33
IPO Date
Jul 10, 2018
Summary
CIK
-
Exchange
TSX
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
CA88166Y1007
Country
CA
Price
0.03
Beta
2.29
Volume Avg.
0
Market Cap
10.58M
Shares
-
52-Week
0.015-0.075
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.31
P/B
-
Website
https://www.tetrabiopharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TBP.TO News
It looks like there's no news available.
